HCP (HCP) Downgraded by ValuEngine

HCP (NYSE:HCP) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a report released on Sunday.

Several other research firms also recently commented on HCP. Bank of America downgraded shares of HCP from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $33.00 to $31.00 in a report on Friday, September 22nd. Morgan Stanley lowered their target price on shares of HCP from $31.00 to $29.00 and set an “equal weight” rating on the stock in a report on Monday, September 25th. Stifel Nicolaus reissued a “hold” rating and issued a $30.00 target price on shares of HCP in a report on Wednesday, October 4th. UBS Group downgraded shares of HCP from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $30.00 to $25.00 in a report on Monday, October 2nd. Finally, Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a report on Thursday, November 9th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company. HCP currently has a consensus rating of “Hold” and an average price target of $30.78.

HCP (HCP) opened at $26.08 on Friday. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17. HCP has a 1-year low of $25.08 and a 1-year high of $33.67. The firm has a market cap of $12,234.34, a P/E ratio of 23.50, a price-to-earnings-growth ratio of 2.78 and a beta of 0.38.

HCP (NYSE:HCP) last issued its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. HCP had a net margin of 27.31% and a return on equity of 8.85%. The business had revenue of $454.00 million for the quarter, compared to the consensus estimate of $440.60 million. During the same quarter in the previous year, the firm earned $0.72 earnings per share. The company’s revenue for the quarter was down 14.4% on a year-over-year basis. equities research analysts forecast that HCP will post 1.94 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in HCP. Sun Life Financial INC increased its position in HCP by 42,675.0% in the second quarter. Sun Life Financial INC now owns 3,422 shares of the real estate investment trust’s stock worth $109,000 after purchasing an additional 3,414 shares during the last quarter. Advisory Services Network LLC increased its position in HCP by 4.1% in the second quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock worth $121,000 after purchasing an additional 150 shares during the last quarter. Fieldpoint Private Securities LLC bought a new stake in HCP in the third quarter worth $147,000. Penserra Capital Management LLC bought a new stake in HCP in the third quarter worth $163,000. Finally, Cetera Investment Advisers bought a new stake in HCP in the second quarter worth $208,000. Institutional investors own 89.88% of the company’s stock.

WARNING: This story was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.chaffeybreeze.com/2018/01/01/hcp-hcp-downgraded-by-valuengine.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply